Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,058
Total Claims
$815K
Drug Cost
795
Beneficiaries
$1,025
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-4%
Opioid rate vs peers
2.2% vs 2.2% avg
-27%
Cost per patient vs peers
$1,025 vs $1,411 avg
-6%
Brand preference vs peers
10.0% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
2.2%
Opioid Rate
195
Opioid Claims
$4,242
Opioid Cost
7.7%
Long-Acting Rate
Brand vs Generic
Brand: 893 claims · $635K
Generic: 8,038 claims · $175K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 94 | $84K |
| Rivaroxaban | 55 | $52K |
| Sitagliptin Phosphate | 36 | $49K |
| Linagliptin | 39 | $48K |
| Empagliflozin | 21 | $39K |
| Semaglutide | 35 | $37K |
| Semaglutide | 13 | $22K |
| Insulin Glargine,hum.Rec.Anlog | 28 | $22K |
| Dulaglutide | 21 | $20K |
| Fluticasone/Umeclidin/Vilanter | 22 | $16K |
| Budesonide/Formoterol Fumarate | 27 | $12K |
| Rosuvastatin Calcium | 325 | $11K |
| Insulin Lispro | 12 | $9,082 |
| Fluticasone/Vilanterol | 21 | $8,952 |
| Atorvastatin Calcium | 685 | $8,936 |
Prescribing Profile
Patient Profile
76
Avg Age
40%
Female
1.02
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About